Some concerns about the Sydney criteria for antiphospholipid syndrome

1 Miyakis S  Lockshin MD  Atsumi T  . International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) . J Thromb Haemost 2006; 4: 295 – 306 .

2 Hughes GRV  . Thrombosis, abortion, cerebral disease and lupus anticoagulant . Br Med J 1983; 287: 1088 – 1089 .

3 Hughes GRV  . Hughes syndrome: the antiphospholipid syndrome. A historical view . Lupus 1998; 7: 1 – 4 .

4 Hughes GRV  . Hughes Syndrome (the antiphospholipid syndrome): ten clinical lessons . Autoimmun Rev 2008; 7: 262 – 266 .

5 Boehlen F  Bader M  de Moerloose P  . Superficial thrombophlebitis of the chest wall associated with anticardiolipin antibodies: antiphospholipid syndrome or Mondor's disease . Lupus 2004; 13: 70 – 71 .

6 Magy N  Gil H  Racadot E  Dupond JL  . Mondor’s thrombophlebitis and antiphospholipid antibodies . Presse Med 2003; 32: 70 – 71 .

7 Wilson WA  Gharavi AE  Koike T  . International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop . Arthritis Rheum 1999; 42: 1309 – 1311 .

8 Rees JD  Lança S  Marques PV  . Prevalence of the antiphospholipid syndrome in primary systemic vasculitis . Ann Rheum Dis 2006; 65: 109 – 111 .

9 Norden DK  Ostrov BE  Shafritz AB  Von Feldt J  . Vasculitis associated with antiphospholipid syndrome . Semin Arthritis Rheum 1995; 24: 273 – 281 .